Strengthening our biology backbone – RDS ‘omics project09/08/2017
We are part of the NCRIS-funded Research Data Services 'Omics project helping to empower modern biologists with better data services and infrastructure.
Genomics Virtual Laboratory30/10/2016
The Australian-made Genomics Virtual Laboratory (GVL) takes the IT out of bioinformatics.
EMBL Australia Bioinformatics Resource Brochure16/10/2015
The EMBL Australia Bioinformatics Resource – BRAEMBL – is a network of bioinformatics expertise, resources and training for Australian life science research.
Ada Lovelace Day Promotional Poster12/09/2015
VLSCI has, with kind permission of the artist (Lisa Congdon, email@example.com) produced a poster to celebrate Ada Lovelace Day, 13 October 2015. This is an international day designed to celebrate the achievements of women in science, technology, engineering and maths.
Life Sciences Computing Bookmark15/07/2015
Situated in the Melbourne Biomedical Precinct, the Victorian Life Sciences Computation Initiative – VLSCI – is ideally positioned to drive this leading global research and teaching powerhouse.
VLSCI Delivering Impact to Researchers Flyer19/02/2014
The role of the VLSCI in providing access to sophisticated computational infrastructure as well as experienced personnel who can foster a collaborative research approach has been critical to the success of many projects across Victoria. Project outcomes, throughput and credibility are all enhanced.
Finding the epicentre of a brainquake02/12/2010
Victoria’s new supercomputer facility is helping to create a new monitoring system for epilepsy. The researchers hope to identify the seat of an epileptic seizure and open up opportunities for surgical intervention.
A better way to diagnose glaucoma02/12/2010
Computer scientist Dr Andrew Turpin and optometry researcher Dr Allison McKendrick are using a supercomputer to try to reduce from years to months the time taken to diagnose the worsening of vision which signifies glaucoma, the world’s second most common cause of irreversible blindness.
Constructing the polio virus – one atom at a time02/12/2010
Jason Roberts has built a moving, three-dimensional simulation of the polio virus from the ground up. He fed data on the structure of the 240 proteins and 60 lipids from which the virus is constructed into a supercomputer. And it put together the virus in a simulated water environment – a jigsaw of more than 3.6 million atoms of which the virus comprised only 900,000.
Finding the Achilles’ heel of parasites02/12/2010
It was once a major challenge to sequence the entire genome of a pest organism to find clues for how to control it. Now, molecular parasitologists are using supercomputers to do just that – and they’re working toward new ways of combating destructive parasites of humans and animals.
What’s in a name? Cancer redefined02/12/2010
Welcome to the brave new world of personalised cancer treatments — where your cancer will be rapidly typed and a personal treatment plan created with the help of supercomputer-inspired analysis.
Data drives probe into cancer crisis point02/12/2010
It’s work that takes significant, but not necessarily huge amounts of, computer power… More important is the expertise of bioinformaticians in knowing how to automate the search for patterns in huge data sets, and generate meaningful statistics from massive amounts of information.
A squishy cell is a healthy cell02/12/2010
Clinicians may soon be able to diagnose and track the progress of diseases such as diabetes and malaria under particular treatment regimes through a patented Lab-on-a-chip diagnostic device. Behind its development is a team of Monash University engineers, their understanding of the complexities of computational fluid dynamics and the supercomputers at the Victorian Life Sciences Computation Initiative.
Understanding drug interactions at the molecular level02/12/2010
Almost half of the currently available medicines act on a single group of molecules - G protein-coupled receptors (GPCRs), which can trigger cellular responses to a wide range of ailments such as heart disease, infections, respiratory disorders, digestive and other conditions. New drugs are predicted to emerge from a deeper understanding of GPCRs at the molecular level. The race is on.